Ma Ida Mohmaed Ali

5PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 25, 2026
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

|Nov 20, 2025
Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.

Ma Ida Mohmaed Ali, Lisa T van der Heijden, Matthijs Tibben

|Nov 16, 2024
A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups.

Ma Ida Mohmaed Ali, A Laura Nijstad, René J Boosman

|Mar 01, 2024
Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data.

Cedric Lau, Ma Ida Mohmaed Ali, Lishi Lin

|Oct 11, 2023
Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone Acetate.

Maaike A C Bruin, Ma Ida Mohmaed Ali, Merel van Nuland

Pageof 1

Frequent Collaborators

3 joint publications

Alwin D R Huitema

2 joint publications

Neeltje Steeghs

1 joint publications

Cedric Lau

1 joint publications

Lishi Lin